YOLFTbeta
Finemedix Co., Ltd.

Finemedix Co., Ltd.

387570 · KQ · Healthcare / Medical Devices

5,440.00KRW-150.00 (-2.68%)

Price History

Full chart

Market Stats

Previous Close5,590.00
Open5,590.00
Day Range5,330.00 – 5,590.00
52-Week Range3,755.00 – 9,230.00
Volume5.45K
Market Cap33.94B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg5,793.30
200-Day Avg6,457.25

About

Finemedix Co., Ltd. manufactures and sells medical devices in South Korea. It offers knives; polypectomy and EMR snares and retrieval nets; hemostatic forceps, injection catheters, hemoclips, coagulation probes, and clearcoajets; and biopsy products, such as disposable, disposable, reusable, and hot biopsy forceps. The company also provides EUS/EBUS products; ERCP baskets and cannulas, and sphincterotomes; and accessories, including distal caps, mouth pieces, and other products. The company was founded in 2009 and is based in Daegu, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Seong-Woo Jeon
  • Headquarters140-9, Yuram-ro, Dong-gu, Daegu, South Korea, 41059, Korea
  • Websitehttps://www.finemedix.com

Leadership

  • Mr. Seong-Woo JeonCEO & Representative Director · b. 1971
  • Mr. Joongbo HwangExecutive Director of Sales Department & Director · b. 1980
  • Mr. Seong-Cheol KimVP & Representative Director · b. 1976

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue8.14B10.15B9.96B9.52B
Growth (%)-+24.71%-1.91%-4.39%
Cost of Revenue3.74B4.51B4.26B4.92B
Gross Profit4.41B5.64B5.71B4.60B
Gross Margin54.12%55.55%57.28%48.34%
Operating Expense5.07B4.77B5.73B7.18B
Operating Income-661.25M873.58M-29.19M-2.58B
Operating Margin-8.12%8.60%-0.29%-27.10%
EBITDA1.51B2.34B906.40M-1.50B
EBITDA Margin18.53%23.05%9.10%-15.72%
Net Income239.58M1.18B-24.15M-1.88B
Net Income Margin2.94%11.58%-0.24%-19.72%
R&D650.75M497.78M554.53M562.40M
R&D as % of Total Revenue7.99%4.90%5.57%5.91%
Interest Expense255.40M198.81M116.61M93.42M
Interest Expense % of Total Revenue3.14%1.96%1.17%0.98%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets18.57B18.53B26.90B25.52B
Total Liabilities7.00B5.90B6.11B6.52B
Total Equity11.57B12.62B20.78B19.00B
Cash1.18B1.89B10.41B3.14B
Net Debt3.70B2.04B-400.51M

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.43B1.38B170.68M-2.63B
Capital Expenditure694.56M336.13M595.45M853.10M
Free Cash Flow-2.13B1.04B-424.77M-3.49B
FCF to OCF148.40%75.61%-248.87%132.39%

Earnings

Report DateDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------
EPS Actual148.50-155.78-75.26-183.3468.56-138.62142.72
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap33.94B
Enterprise Value30.76B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.97
Price / Book1.79
Revenue (TTM)11.43B
Gross Profit (TTM)5.93B
EBITDA-234.18M
Profit Margin-5.24%
Operating Margin19.60%
Return on Equity-3.12%
Return on Assets-3.02%
Shares Outstanding5.43M
Shares Float3.09M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%